非择期胸腹主动脉及内脏动脉受累动脉瘤腔内修复的系统综述与荟萃分析
该系统综述与荟萃分析纳入18项研究共953例患者,评估非择期腔内修复胸腹主动脉瘤和复杂腹主动脉瘤的指征、技术与结局。技术成功率94.4%,总体手术相关死亡率16.8%,破裂病例死亡率(24.5%)显著高于完整病例(11.8%)。脊髓缺血和3级脊髓缺血发生率分别为12.3%和5.2%,破裂病例均更高。
要点
- 非择期腔内修复技术成功率高(94.4%),但手术相关死亡率和脊髓缺血风险在破裂病例中显著升高。
- 破裂病例手术相关死亡率24.5%,完整病例11.8%(P < .001)。
- 胸腹主动脉瘤亚组结局似乎不受破裂状态影响,但差异无统计学意义。
核心结论
- 非择期腔内修复胸腹主动脉瘤和复杂腹主动脉瘤的指征异质,技术成功率高但破裂病例早期死亡和脊髓损伤更高。
- 胸腹主动脉瘤的结局似乎不受破裂状态影响。
研究设计与样本
- 系统综述与荟萃分析,遵循PRISMA指南并在PROSPERO注册。
- 筛选687篇文章,最终纳入18项研究共953例患者。
- 胸腹主动脉瘤占68%(Crawford I-III型51%,Crawford IV-V型49%),复杂腹主动脉瘤占32%。
主要发现
- 技术成功率为94.4%。
- 总体手术相关死亡率为16.8%(95%CI 0.13-0.22),破裂病例24.5% vs 完整病例11.8%(P < .001)。
- 脊髓缺血 pooled 率为12.3%(破裂21.9% vs 完整8.9%,P = .007),3级脊髓缺血为5.2%(破裂8.5% vs 完整2.2%,P = .02)。
- 永久透析 pooled 率为3.6%(破裂6.1% vs 完整1.7%,P = .08),呼吸事件为14.1%(破裂20.7% vs 完整9.3%,P = .024)。
- 胸腹主动脉瘤亚组手术相关死亡率为18.7%(破裂24.8% vs 完整12.6%,P = .08),脊髓缺血16.4%(破裂21.9% vs 完整9.7%,P = .06),3级脊髓缺血5.6%(破裂8.1% vs 完整2.8%,P = .08),透析5.4%(破裂7.2% vs 完整2.6%,P = .36),呼吸事件18.2%(破裂23.1% vs 完整10.5%,P = .10)。
关键数值与推荐
- 非择期治疗指征包括破裂(包含性破裂或自由破裂)、症状和大动脉瘤直径。
- 使用的移植物类型:分支型内移植物54%,医师改良/原位内移植物30%,平行移植物14%,开窗型内移植物2%。
临床怎么用
- 对于非择期胸腹主动脉瘤和复杂腹主动脉瘤,腔内修复技术成功率高,但需警惕破裂病例的高死亡率和脊髓缺血风险。
- 胸腹主动脉瘤非择期修复的结局可能不受破裂状态显著影响,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Thoracoabdominal aortic aneurysms (TAAAs) and juxta/pararenal abdominal aortic aneurysms, reported as complex aortic aneurysms (cAAAs), represent a technical and clinical challenge with endovascular repair embodying a preferred option for high-risk patients. However, in case of nonelective presentation, both technical and clinical management and outcomes remain limited in literature. The aim of this study is to report indications, treatments, and outcomes of nonelective endovascular repair of TAAAs and cAAAs. METHODS: This study is a systematic review and meta-analysis performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA) and after PROSPERO registration. Primary end points were the indications, technical success, and procedure-related mortality. Secondary end points were spinal cord ischemia (SCI), grade 3 SCI, dialysis, and respiratory events. Meta-regression was performed for nonintact vs intact aneurysms. Subgroup analysis was performed in studies involving exclusively TAAA repair. RESULTS: Of 687 articles screened, we selected 18 articles involving 953 patients: TAAAs were 68% (51% Crawford I-III and 49% Crawford IV-V) and cAAAs were 32%. Indications for nonelective treatment were contained of free rupture, symptoms, and large aneurysm diameter. Branched endograft, physician-modified/in situ endograft, parallel graft, and fenestrated endograft were used in 54%, 30%, 14%, and 2%, respectively. Technical success was 94.4%. Overall procedural-related mortality was 16.8% (95% confidence interval: 0.13-0.22; nonintact: 24.5% vs intact: 11.8%; P < .001). Pooled rate for SCI and grade 3 SCI was 12.3% (nonintact: 21.9% vs intact: 8.9%; P = .007) and 5.2% (nonintact: 8.5% vs intact: 2.2%; P = .02), respectively. Pooled rate for permanent dialysis was 3.6% (nonintact: 6.1% vs intact: 1.7%; P = .08) and for respiratory events 14.1% (nonintact: 20.7% vs intact: 9.3%; P = .024). Subgroups analysis for TAAAs reported procedure-related mortality in 18.7% (nonintact: 24.8% vs intact: 12.6%; P = .08); SCI, grade 3 SCI, dialysis, and respiratory events occurred in 16.4% (nonintact: 21.9% vs intact: 9.7%; P = .06), 5.6% (nonintact:8.1% vs intact: 2.8%; P = .08), 5.4% (nonintact: 7.2% vs intact: 2.6%; P = .36), and 18.2% (nonintact: 23.1 vs intact: 10.5%; P = .10), respectively. No statistical differences in metaregression for nonintact vs intact TAAAs. CONCLUSIONS: The indications for nonelective endovascular treatment of TAAA and cAAA are heterogeneous. Technical success is elevated while early mortality and spinal cord injuries were higher for ruptured aneurysm. Interestingly, TAAA outcomes seemed not to be influenced by rupture.
引用
- Spath P, Campana F, Tsilimparis N, et al. Systematic review and meta-analysis on endovascular repair of nonelective thoracoabdominal aortic aneurysms and aneurysms involving visceral arteries. J Vasc Surg. 2025. PMID: 40885460. doi:10.1016/j.jvs.2025.08.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。